ITGR - Earnings call transcript Q1 2022 | Integer Holdings Corporation

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Good day. My name is Savannah, and I will be your conference operator for today. At this time, I would like to welcome everyone to the Integer Holdings Corporation First Quarter 2022 Earnings Call. [Operator Instructions]. And I would now like to turn the conference over to Tony Borowicz. ahead. go Please

Anthony Borowicz

and Thank Integer's everyone. me joining and Executive us, are and Vice Good Financial Chief Quarter you XXXX to Officer. Officer; Chief and First Dziedzic, With Garland, Earnings welcome Executive Joe President morning, President for Jason Conference today Call.

reflect periods reminder, indicated. the today data of results we and a consolidated Integer As discuss results the for the

discuss we During will some non-GAAP our call, measures.

presentation press today's call, release non-GAAP includes cause statements. refer measures, will the opening please Joe to could differ presentation, For today's our are reconciliation of of discussion SEC earnings note to that the which website to of these forward-looking schedules provide for today's a our his a filings that results at Please risk Jason actual XXXX, and today's over Please that, back Aran turn the review line and our announced XXXX up trending call acquisition our factors come then on On review comments the of performance refer financial on appendix available results company's materially. the With Joe the your will we recently product his and detail Joe. will to then more the provide our additional full insight questions. remarks, for year Biomedical. first on adjusted provide will closing call guidance. open the to for quarter and I'll integer.net.

Joseph Dziedzic

strategy. joining especially remaining the Tony, also these for today, executing times, Integer during for you, who to on to call dynamic everyone focused have deliver customers Thank our our and thanks Associates the continued while

have last earnings expected We guidance They that income expectations quarter operating we for we prior share did demonstrate were the shared that $X the adjusted of the to guidance. when was the our $XX million. to our demand on good which be as guidance. We to guidance We've quarter told with believe deliver I from and investors exact within we Our first the our provided but first that we were our of we we fourth quarter continue can full the visibility quarter, results on we provide first same about that year. quarter, not sales projecting, for million with that profit consistent year current call. calls last were customers

sales due quarter our The January into to largely flat COVID-related constraints. first a and chain basis, quarter full the both supply were on and the for year-over-year high about was absenteeism, first This year. the organically incorporated guidance

year-over-year and labor we Our invested our associates ramp in demand direct from meet up and the income as adjusted grew XX% growing our customers. declined XX%, training operating overtime to to

levels sales inventory inventory the second our year. quarter about and We the of staffing also remainder margins the $XX for rest and the in positioned the sales support in to deliver of to well growth the We approximately double-digit also gross quarter the improving million through feel year, increased while by first year. our growth remainder are of the

deliver even financial excited our earlier joined our include innovation together, we're updated can Aran's profit. more and and that Integer are month, We XXXX confident Biomedical we for to Aran sales We customers. this that guidance

few at Aran an Biomedical added Our X, industry in acquired annualized about while the we more rates. slides. biomaterial used also Aran of adding technologies have share April markets accretive capabilities to $XX X high-growth in BioMedical, On excited million in differentiated recent acquisitions cardiovascular I'm sales implants. on approximately next leader growth

are in the our and offer medical markets. in associates fits a add is to located Integer medical XXX grow of medical textiles, been strategy customers the coatings developing to targeted offering highly end to technologies advanced was creates model. high-growth the Their meeting devices, perfectly combined device high-growth for capabilities focus devices. development and new to gross to end-to-end excited capabilities XXXX leading will gives delivery Galway, million Integer's companies has over and Integer's owned solutions another believe to of are the next in a commercial most sales implanted our that and to We with medical years. device coverings Aran's Aran's medical welcome portfolio projection and sales provide capabilities with and XX% hub devices. of million least sales annually $XX with over million of privately to accretive of comprehensive few and the deal at and business implants XX differentiated that limited model With we been grading up high-precision expand our proprietary on an paid acquisition XXX in for growth Ireland into capabilities innovative and are XX% end-to-end will offering but is solutions, fast-growing XX years. Aran acquisition strong XXXX solutions. We We Aran's us designed differentiated a pipeline, access confident products, offering this pipeline systems synergies our deliver biomaterial broad to their earn-out This device sales complex will with proprietary has our for serving targets. EUR which strong markets. differentiated for in outsourced Aran upside EUR combined includes combination outsourcer, margin confidence

Our for invested we rise we return than return this expect to a within average cost be in above of by range third From capital the to acquisition for expect range year but X. Aran target that and weighted quarter, be our accretive greater of to leverage capital the perspective, by our year. quarter on back will our EPS be XXXX X

serve customers the and of During call, we through earnings the emerging the life entire serve, cycle highlighted maturity we growth how product into our last phase the our across each phase. markets we for

this customers together. funding markets the should, differentiated generate opportunity where shared our are the on The procedures we our focused and growth our chart and where accelerated We most therefore, capabilities receiving highlight that by we Aran's how significant see the growth. to also focusing on are investments green circles accelerate are innovation

high-growth structural one of device heart devices, in where example access and outsourced can systems portfolios highlighted and now offer subassemblies. implants the demonstrate our together comprehensive of the of over and customers in and hand slide side products create the more Thanks I'll in focus neurovascular enable for and of now we've have more the our Aran our to markets, devices markets. This vascular heart, how device complex believe of high-growth all more This Integer peripheral Aran delivery Jason. end-to-end like usual full broadest Aran's offer offering alignment customers' Aran markets. demonstrate the slide, Aran, same strategy of been right an and customers these to market. is value and on in than vascular. deliver devices. we a the structural to example that to to the capabilities markets create is we peripheral call high-growth cardiovascular proposition neurovascular and the On executing. capabilities with is provide high-growth Integer Integer outsourced innovation to now has The specific the procedures medical applies together design components other a what I'll detail Integer by can one on targeted outsourced

Jason Garland

product trends XXXX call. Good provide conclude I'll Thank sales adjusted reflect our been first you, summarize Aran updated quarter with our results, Joe. joining more Thank outlook, details for XXXX impact of line our financial morning. our our you which on and to has again the acquisition.

$XX negative third COVID-XX quarter excludes differences first and first quarter million the adjusted impacted consistent of than over the first sales same were by fourth constraints. Both XXXX and first million, quarter the and were consistent with operating of fourth February a income in caused Gross and and impact X% due first sales year. January year. earnings guidance, Oscor first quarter ongoing is chain X% with growth, XXXX, the growth margins versus included high currency and First XXXX, with quarter absenteeism the was our constraint. surge the supply supply in expectations. which quarter there quarters by period Organic first realized our of quarter for were to of from sales was consistent quarter not the In a higher those our delivering quarter, the decline sales $XXX though last last chain of which labor

higher-than-normal to XXXX. We by continued caused as direct delayed high training overtime labor through from rest we salaries inefficiencies as are the to the and for the incremental headwinds of support growth well material face costs, associates hiring

highest XX% Direct mentioned, in get increase were With continued hiring. to labor quarter have XXXX. we months the of Joe last up better Having versus the X on as half the in associates traction that of As us to the first second Furthermore, of coupled second order with needed company in resources ability with XXXX and history. strong gives entered backlog we quarter grow our our in confidence demand quarter. inventory the

deliver increases. Operating costs. annual to growth the positioned was The of the sales well RD&E from margin are year. expense, approximately primarily and drive SG&A Oscor, of leverage in including salary training addition benefits well remainder and line year-over-year our inefficiencies as improved December to as is higher reduction growth We operating to acquired expected top of the for grew double-digit and which the due XXXX

in XXXX year We and expense, remainder expect annual operational for incentive XQ the timing the to SG&A the expense from imperatives. increase of due marginally strategic of to investments increase 'XX compensation salary

continue we increase our will As of in discussed markets. drive earnings our call, development support that to growth programs focused our in last product revenue

customer year-over-year expense increase to support these in by to higher programs. quarter the In Oscor, the growth addition resources RD&E driven first was

this We expect about remainder level of expense remain the year. quarterly at for to RD&E the

constraints of $X.XX year, of adjusted XXXX. compared the was provide first earnings the the in EBITDA at of $X.XX from XX% $XX decline on $X delivered quarter to net adjusted decrease income, a XX% diluted million adjusted compared million, net share, quarter Our of versus with was decreased we income to color adjusted million last income $XX million, the of the operating $X or million and on $XX the quarter year, more debt delivered per down the prior a of the first down a interest the XX% in year, quarter XXXX adjusted expense, first headwind To third improvement $X from our net unfavorable of was by basis. repayment supply in savings impact driven our and continued labor captured by January the adjusted a versus the by focus chain million to surge, refinancing income XXXX. debt compared offset FX primarily the direct slightly XXXX, last addition COVID-XX by quarter adjusted year-over-year high with driven absenteeism lower by from on and partially created Oscor

tax the XX.X%. being adjusted quarter. This headwind of adjusted XX.X% was due year-over-year effective million in effective rate $X the XXXX a rate created Our in to first tax

quarter first XXXX of while the compensation, points Accounting discrete from a basis of quarter the total was stock-based headwind. favorable unfavorable. first XXXX same XXX the to The of benefited year-over-year item discrete for ETR related item in

million quarter, as and For the we generated This in the adjusted to includes quarter. $X to operating deliver expect customer associated from first typical and XX% flows be cash demand customer positioned in of cash We we our of million incentives cash meet and rebate and in $XX rate second increase full are expenditures short-term payments. effective half ensure inclusive million as capital $XX million in second sales year to well tax growth first inventory flow quarter for our approximately generated free the flow, in XXXX, activities quarter in the to $XX between XX.X%. the

constraints into chain first collection. impacting timing high supply the delayed EBITDA in total the of at to latter target and quarter were of Despite was first ratio million sales given February absenteeism Additionally, quarter, of $XXX mentioned, net the range. the the the these January end Xth our and part X.Xx leverage adjusted debt within decreased trailing quarter the million headwinds, $X debt and our

include to reporting Please line will line year. call note in earnings February changes discussed our sales product conference the We in line now discussion this our transition product of of a these product sales.

to in products product to procedures associated of AS&O Trailing the As first increase includes alignment access reported continued well product underlying quarter heart fourth sales rate across a this CRM cardiovascular. our of the all our CRM&N neuromodulation with to Cardio by line Vascular Vascular the of quarter constraints, our and lines. double-digit and Cardio the their markets. and product XXXX. within in year-over-year in of absenteeism strong strong with Beginning as Trailing was portable and neurovascular the move continued demand, and an across the quarter reminder, growth compared with sales from particularly fourth structural medical as year-over-year and first quarter in sales were supply CRM growth, implantable medical XXXX into market development the growth and XX% up XX% improve and active quarter reflected move chain product from X first as all labor the prior by the neuromodulation direct delivery growth driven device quarter the revenue. first components in up line, first growth Despite

Moving offset X% continued primarily quarter to absenteeism supply grew chain by sales in components, cardiac labor was rhythm the lead long management the and sales growth, constraints and growth up X-quarter as customer remains demand neuromodulation, the Oscor recently Trailing direct for acquired from XX%. higher while sales year-over-year strong. strong first

Advanced Moving line. product & Orthopedics our Surgical, Medical to Portable

in declined as that decline year-over-year portable decreased demand Surgical last ventilator and year, Our medical year by for component. noted, first prior quarter Advanced decline peaked Trailing patient quarter X% demand pandemic. sales the driven X% a driven by previously COVID-related versus to the Orthopedics sales due monitoring declined during lower a for components and and fourth in

product discussion we'll wrap with Electrochem, nonmedical Finally, up the line segment. our

by sales range sales expectations recovering million we of of X for compared negative market. and now to recent quarter billion, guidance to of sales X% also from XX% XXXX. Trailing supply to to chain to expect X-quarter the updated range. XXXX. Aran XX% driven energy to now expect increasing the year-over-year, On are the of XXXX, of grew been despite impact reflect First an sales XXXX. outlook includes sales, remaining This in $X.XXX be grow sales basis, $XX We'll lifted the Starting increase acquisition which market. added our continued for in projected XX% with sales months to an the compared to to improvement our energy BioMedical impacts transition have billion we organic XX% of our the $X.XXX we increased X% to still Aran by constraints

the first growth continue expect and to will EBITDA supply realize incorporates year quarter the expect improve, will ability growth half approximately we the and updates from just with sales, the million EBITDA $X customer positioned quarter discussed approximately the sales second our direct on the million deliver Aran, growth. XXXX introductions. the We rest to of our from expect impact sales believe of be and chain Aran. focus the manage we from of XX% new to which double Adding in Further, for which, labor grow the digits challenges Having well the P&L, continue adjusted increasing grow product to of between demand. we $XXX $XXX digit sequentially I'll like versus we as second now of year-over-year XXXX is adjusted million, to to double outlook, to inventory on contribution XX%

million growth We to expect XX% to be adjusted XXXX million between operating reflecting to $XXX million includes $XXX of and $X income Aran. X% from

continuing XXXX from reflects inefficiencies in volume leverage operating it income and quarter training in the run and rate starting of the As during second discussed margin previous the second XX% and rates results. Adjusted that tax an quarter of XX.X% be EPS our $X.XX to reflecting outlook. is to unchanged the in remainder growth of to $X.XX I expected effective between the from rate X% discussion described XX%. This adjusted earlier, the adjusted costs, reduction an and adjusted EBITDA growth also rates OpEx for to assume in assumes between the improvement the half first

be million, We which the have between the interest interest expense expense for $XX $XX adjusted incremental incorporates acquisition. updated Aran to our million financing and

Consistent our million expenditures in outlook to our impact million flow the we million free operations million to close, with I from business of are we between to $XXX to Aran. strong updated cash cash cash as between and maintaining in strategy, drive for $XXX on expect As invest the capital both continue generation we flow $XXX $XX in growth.

$XX million We which over prior $XX spending. in expect run spend is between the rate an to and our million, year's increase

expect to our adjusted leverage X.Xx million with adjusted to EBITDA between target expect X.X $XX to We $XX million by net X.X to X.Xx total and the year of range end debt EBITDA. ratio to reduce within our

second target end you. range targeted I'll turn the that, due call third range anticipate within the Although exceeding with of in quarter XXXX. And to back of our quarter to leverage Aran our we to the back XXXX Joe. the the we be expect acquisition, slightly by Thank

Joseph Dziedzic

uniquely Jason. our their positioned serve is to Integer Thanks, phases across customers of life cycles. all product

to for continue add both inorganically, customers. We differentiated and organically capabilities, delivering while our

rate our positioned accelerate while growth margins. Our structured line disciplined us have product expanding sales strategies and to well

We will updated growth are we to staffing were believe acquisition the our our the for on first expectations of of results double-digit our guidance. but our with our inventory deliver the consistent confident and second have we levels created. I'll we full the financial by We approximately culture our quarter performance and of quarter up Aran financial year deliver wrap reiterating the well because in with and guidance Biomedical, us position and rest objectives year.

our markets by example solutions differentiated focused We We us accelerate of this enabling their innovation high-growth strategy that comprehensive by excellent strategy execute our close how an to I'll will dividends. in strategy paying deliver success. adding enable and by more service on is capabilities our customers. customers providing with growth believe our continue to to

with annual for volume next-generation Nevro partner outsourced provide a a their platform, on that design in-source happy have to wanted been manufacturer second starting for including strong announce we Nevro Nevro's regulatory them sole into through partner supporting assembly in to and success commitments. to to decide with back be continuity. pulse multiyear high-frequency of their a them generator stimulation agreement many am implantable the they have approval led and their ultimately to of their manufacturing. the spinal We source I but IPG years, to business high-volume signed development XXXX cord supply a

will sole We be their current source to product. generation continue for their

both partner We serving believe and product. have differentiated components to our call vertically the this the how customers' service, moderator We turn continue our joining integrate now for of customers choice. we call. of of for I morning. also Nevro's partnership and will is plan Integer agreed to into our IPG further portion our manufactured our back you technology this of fulfilling to the being vision success the and Nevro Thank Integer Q&A demonstrates call with for our

Operator

come will from our KeyBanc. [Operator first Instructions]. question Matthew with Mishan And

Matthew Mishan

X-part you as be Joe, your So like a to think this question. going -- is about

about outlook go versus are of or are couple of particularly uncertainty ago, think cause in you point second a today to raw as could this that through at challenging that, the materials visibility your you confident then outlook? of As summer? months the any the more part components are there less you some And that that

Joseph Dziedzic

the questions, great -- the our mid-February. versus in. feel our better about rest advantage call even that I'll earnings start year. the the get at heart all had chain actually few we ago, Matt, We months being of challenges which of dynamic in a supply with the the living in environment we're of And

had call. So our we quarter earnings fourth

in a absenteeism already surge from the U.S., had experienced we heavily a in January dramatic Europe. So the in COVID in bit little surge

already off how We in still February. February, seen but tapering had also impacted was it

that expectations the were flat fourth on able we So incorporate mentioned quarter operating with landed we the internally our profit projecting. operating right quarter impact I we as were profit. to the first revenue as well for being in

actually a labor thinking about more rest we've the better feel of able inventory. million quarter. of terms direct in year mid-February, to We versus first associates lot because $XX of where we the within the today about we X% been added So build are

into up in quarter. -- first first we're So XX% quarter the

quarter with the had. X to good really orders We've got X, quarter very that highest we've one in remarks, year. the of labor growth on things the the that need the we prepared Jason rest really next visibility the measure the quarter of we months. got That's good of amount for the direct second and ever traction in we the in fulfill the mentioned closely. So entered adding we

feel from good about the And so we really customers. demand

first of year, feel of COVID quarter rest grow. as year in a are feel really results really like to the behind as lot us for now that because the we're investment have much the though the prevented done, financial we about the would glad be adding headcount and us shipping good we good have So But reflect we even to we the the from the and able feel we about the liked. and surge we where product got rest

one Your we of very next question, that continue the to the components or closely. raw manage That's areas materials.

heard to the you've they disruptive the to industry about when it's the run availability everybody very built had got committed -- We've talk challenges the that that the You've can't plant material material. manufacturing same suppliers plant because your of on date ship in those and receive lines.

that, $XX through be adding of schedule times to being managing that and of plant. first been materials, have that the manage. helps dialed the year we've able us within particular with to able we've well managed the lead so pretty We we're We helps because There quarter to them. million inventory And are challenging the better the one it been like think that of during components also impact into plan are go we've inflation. PCBAs resins long into and that feel

of getting a costs benefit inflationary inflation. number this -- of the down, that, we of programs pressures the the helping You've launched industry we're We've last advantage that's in talk have and we of heard the drive offset some year, material everybody about to year.

guidance year the our hitting with second Their and to in biggest guidance. and seems So growing materials the that and year on quarter, do be material our be raw the we for sit good year the entering second not the components we rest of to of rest closely about able labor, digit to it. the suppliers. double and deliver the full quarter And feel we but and where process to certainly availability, really necessarily managing we're labor issue have

confident feel We the and expected the first rest delivered, quarter in of we we year. the results that

Matthew Mishan

first like about, is strong customers back to that in been some order from Or have record to talking positive that underlying were is Okay. quarter? momentum due may a that orders in filled and due you recovery just guys that be book And business? the the really able to not then the your

Joseph Dziedzic

I X variables. think there's

think to look of of strong for them recovery the the the I we is year. certain rest one as

new launching the and have that product to development of manufacturing be into in moving We products we're sites order we're ramp out that customers' are and up, introduction. our ramping to able to

see we factor this we growth. COVID as So able that that But related built probably the is one volume of that were ship planning half of volume. absolutely because in quarter. to, inventory There's first to we to surge, we were not the

the entered probably hand. everybody give we and that a as so greater doing see we supply as to encouraging customers, third any Everyone our visibility. advance And with to variable chain in in And manufacturing We're supply placing volume industry with ourselves our our well is and further in orders We're this suppliers base. environment. in that do. quarter then there's the but where

supply their base. With

doing Our it. customers are

manage for supply it's the giving of visibility better our doing what is year, able for which in of is that the demand better to better So guidance And does to everybody the we visibility increases gives our confidence rest the us even year. it the ultimately what chain. it's be to the rest think

Matthew Mishan

over lot obviously moving reflective then guidance of lastly is on couple that pieces just Okay. the And there's last a Is of months. guidance, of -- Aran. the the

interest there pieces upfront a that moving bit. are dilutive little down little So Is the the other some change or be otherwise. a of to is sales considering bump rate no there? EPS because there

Joseph Dziedzic

in is added change our only the we So Aran. guidance

the for only EPS of our months to so accretive of it's -- $X a X in And debt Aran, of income. to change is to we got the adding dilutive AOI, we EPS. flat because and the accretive And the Aran XX for few get the adding time $X expect by pennies of full million guidance million be on sales we've to year we get and XXXX, EBITDA,

Jason Garland

there change it only there. only changes The --

Operator

Instructions]. [Operator

Our Sidoti Sidoti from next question & will Jim Company. with come

James Sidoti

they're distributed Integer? and company distribution about going now their products bit what look a is you as Aran little of stand-alone talk that Can to a how like and part

Joseph Dziedzic

I be our And and to manufacturing us the develop much didn't a our to with into commercial vertically delivery us offerings and combination significant integrate into industry. allow we can access is offering, of of Aran one heart capability even need things customers. and a our comprehensive and scale offering Well, And than synergies comprehensive synergies half more -- advantages to love going and open we -- biggest we of the pipeline, to the is devices more of about think high-volume comprehensive vertically more we one think about the biggest with were a scale combining to even gives Aran Aran and have we is integrate really the the opportunities to their their our able customers most commercial the development And deal, that The now but we pipeline talked development we justified its which deal comprehensive the our structural because bring Aran. excited differentiation on half we Integer's Aran's their on to. own More systems the customers. offer structural will programs, lot that for on think, manufacturing and the we make help program deep comprehensive in last to of think pipeline offering partner their a they very in solution to they're demonstrates working heart, call. has ability about pipeline get to development Aran pipeline and stood earnings then the more more didn't which really on than up is ability we're ramp

would our to at capability. the over to to and their product that build with XX% So they and that customers XX% Aran's least next that your we we pipeline that growth think growth we few expect into more we accelerate even see years can with have now get through that expect our with combination

James Sidoti

salespeople were independent for the that specific or And are it after reps? But combined? distribution, direct direct they Okay. reps, will now how companies X using -- the

Joseph Dziedzic

development today engineers Integer customers very closely had work we're the a similar that with different customers' now those their selling obviously teams they we comprehensive more given we with are. What's a the same and and our customers their are. offer, than much to same they are work have engineering manner we in our scale with deeper model portfolio team, They same to is engineering size

to capabilities, So the structural technologies talking devices engineers enabling engineers selling approach going market with differentiated go-to-market neurovascular their be and devices, peripheral it faster. them art to to get same the vascular, and

James Sidoti

to a due sounds R&D It is in And on? over the like of is Oscor? quarter. going million a Okay. then the else that going Jason, primarily stay $X little to addition up it's Or the folks something Is from that question, there way.

Jason Garland

great Yes, that's Jim. a question,

we've the about, So the probably through. expense, of we to Oscor resources X/X programs little it always for focus a and about, as and talked of about timing in resources and But rate areas more is flows growth. bit, right continue that talking as markets that of as program that that, the how our of that grow. in and focus we've being a with and now, in really line XQ year. that run side that see reimbursements investment rest the the The been high-growth had continued and of the continue absolutely revenue rest There's of those piece customer to that revenue, we of grow well we

Operator

Our will Wasserman come next Benchmark. with question from Bob

Robert Wasserman

that this wonder of scale, on whether of timing Just talked this little Aran components? round on or started to there color close contracts the about Nevro contract that in you your we earlier what terms will be if either a in more could it contribution from also when was any contract and you morning also the and the Oscor provide

Joseph Dziedzic

the Great. question. Bob, thanks for

and uniquely from as them. serve So their were they a source, Nevro partner strong been on inception for second were positioned we we think to Nevro, their with looking we've

current publicly so We're And generation we're building with plan up they've their is next-generation their working plants them what think late their running. device. the on which year, to they the is assemble thing this I by to expect have they latest and device said

introduced. both components our support agreement. be we'll assembly will ensure on for they volume as any commitments need over, incremental components start doing they what or a They So there and their of assembly terms And and their if was their and they're launch integrated the IPGs. We'll introduction ramp that well were vertically that that well We'll them as they be they It's commitments multiyear to year. now the volume whenever go through their we first There's next-generation components, ensure and IPG need assembly. that ever. for December in volume they produce manufacture meet planning additional product have work the products and that assembly. in as all them in quarter to to get do as to they the long-term of the above first results. them as results score that as of support them into there their transition additional obviously, of We'll into as time they be providing that the that own with their support last share

results. the and about already. how outperform in well well additional our We're to synergies quarter. in excited integration the you of to sales working the performing. really the and inorganic, rest how that the them is and So that they're going about in first year-over-year the excited expect basis, had on combination see million the continue strong about they to start is year. It $XX we're year. a great a we We're It's commercial had on first very quarter, a Oscor And

Operator

additional I'd [Operator Instructions]. any Mr. closing And back turn remarks. to there's call questions. like no the for to Borowicz further

Anthony Borowicz

well joining today. for we call presentation will The everyone, today. website the call the available Thanks, reviewed as Great. of be just our this as on replay

in you. forward taking for include look questions, the that today. call your and thank follow-up to Integer, you interest Thank I your does and for So

Operator

conclude conference. participation, disconnect. this will Thank you your you And for and today's may now

Integer (ITGR) 1 May 222022 Q1 Earnings call transcript